HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subacute inflammatory demyelinating polyneuropathy in children.

Abstract
Reported are five children with subacute demyelinating polyneuropathy. All patients had a monophasic disease, progressing over 4 to 8 weeks and characterized by predominantly motor features, areflexia, minimal or no cranial nerve abnormalities, no autonomic or respiratory involvement, elevated CSF protein, electrophysiologic evidence of demyelination, and good response to corticosteroids. A benign course with full recovery was the rule.
AuthorsM Victoria Rodriguez-Casero, Lloyd K Shield, Andrew J Kornberg
JournalNeurology (Neurology) Vol. 64 Issue 10 Pg. 1786-8 (May 24 2005) ISSN: 1526-632X [Electronic] United States
PMID15911813 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Prednisolone
Topics
  • Adolescent
  • Age Factors
  • Anti-Inflammatory Agents (administration & dosage)
  • Child
  • Child, Preschool
  • Chronic Disease (classification)
  • Disease Progression
  • Female
  • Humans
  • Male
  • Motor Neurons (physiology)
  • Muscle Weakness (diagnosis, etiology, physiopathology)
  • Muscle, Skeletal (innervation, pathology, physiopathology)
  • Neural Conduction (drug effects, physiology)
  • Paresis (diagnosis, etiology, physiopathology)
  • Peripheral Nerves (pathology, physiopathology)
  • Polyradiculoneuropathy (classification, diagnosis, physiopathology)
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (classification, diagnosis, physiopathology)
  • Prednisolone (administration & dosage)
  • Reflex, Abnormal (drug effects, physiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: